Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 60

1.

Anticonvulsants for cocaine dependence.

Minozzi S, Cinquini M, Amato L, Davoli M, Farrell MF, Pani PP, Vecchi S.

Cochrane Database Syst Rev. 2015 Apr 17;4:CD006754. doi: 10.1002/14651858.CD006754.pub4.

PMID:
25882271
2.

Potential for treatment of severe autism in tuberous sclerosis complex.

Gipson TT, Gerner G, Wilson MA, Blue ME, Johnston MV.

World J Clin Pediatr. 2013 Aug 8;2(3):16-25. doi: 10.5409/wjcp.v2.i3.16. eCollection 2013 Aug 8. Review.

3.

Practice experience in the treatment of infantile spasms at a tertiary care center.

Thodeson D, Sogawa Y.

Pediatr Neurol. 2014 Nov;51(5):696-700. doi: 10.1016/j.pediatrneurol.2014.07.019. Epub 2014 Jul 22.

PMID:
25175384
4.

Newer anti-epileptic drugs.

Aneja S, Sharma S.

Indian Pediatr. 2013 Nov 8;50(11):1033-40. Review.

5.

A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Frye RE, Rossignol D, Casanova MF, Brown GL, Martin V, Edelson S, Coben R, Lewine J, Slattery JC, Lau C, Hardy P, Fatemi SH, Folsom TD, Macfabe D, Adams JB.

Front Public Health. 2013 Sep 13;1:31. doi: 10.3389/fpubh.2013.00031. Review.

6.

Effects of epilepsy treatments on sleep architecture and daytime sleepiness: an evidence-based review of objective sleep metrics.

Jain SV, Glauser TA.

Epilepsia. 2014 Jan;55(1):26-37. doi: 10.1111/epi.12478. Epub 2013 Dec 2. Review.

PMID:
24299283
7.

Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults.

Linde M, Mulleners WM, Chronicle EP, McCrory DC.

Cochrane Database Syst Rev. 2013 Jun 24;6:CD010608. doi: 10.1002/14651858.CD010608. Review.

PMID:
23797674
8.

Treatment of infantile spasms.

Hancock EC, Osborne JP, Edwards SW.

Cochrane Database Syst Rev. 2013 Jun 5;6:CD001770. doi: 10.1002/14651858.CD001770.pub3. Review.

PMID:
23740534
9.

Adrenocorticotropic hormone for the treatment of West Syndrome in children.

Shumiloff NA, Lam WM, Manasco KB.

Ann Pharmacother. 2013 May;47(5):744-54. doi: 10.1345/aph.1R535. Epub 2013 Apr 19. Review.

PMID:
23606552
10.

Pharmacotherapy of focal epilepsy in children: a systematic review of approved agents.

Arya R, Glauser TA.

CNS Drugs. 2013 Apr;27(4):273-86. doi: 10.1007/s40263-013-0048-z. Review.

PMID:
23515971
11.

Vigabatrin for refractory partial epilepsy.

Hemming K, Maguire MJ, Hutton JL, Marson AG.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD007302. doi: 10.1002/14651858.CD007302.pub2. Review.

PMID:
23440814
12.

Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials.

Bodalia PN, Grosso AM, Sofat R, Macallister RJ, Smeeth L, Dhillon S, Casas JP, Wonderling D, Hingorani AD.

Br J Clin Pharmacol. 2013 Nov;76(5):649-67. doi: 10.1111/bcp.12083. Review.

13.

A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures.

Tulloch JK, Carr RR, Ensom MH.

J Pediatr Pharmacol Ther. 2012 Jan;17(1):31-44. doi: 10.5863/1551-6776-17.1.31.

14.

Effect of second-generation antiepileptic drugs on diplopia: a meta-analysis of placebo-controlled studies.

Han H, Qu W, Kang H, Hu X, Zhen G, Zhu S, Xue Z.

J Huazhong Univ Sci Technolog Med Sci. 2012 Aug;32(4):557-62. doi: 10.1007/s11596-012-0096-5. Epub 2012 Aug 11.

PMID:
22886970
15.

Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Go CY, Mackay MT, Weiss SK, Stephens D, Adams-Webber T, Ashwal S, Snead OC 3rd; Child Neurology Society; American Academy of Neurology.

Neurology. 2012 Jun 12;78(24):1974-80. doi: 10.1212/WNL.0b013e318259e2cf.

16.

Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations.

Piedad J, Rickards H, Besag FM, Cavanna AE.

CNS Drugs. 2012 Apr 1;26(4):319-35. doi: 10.2165/11599780-000000000-00000. Review.

PMID:
22393904
17.

Vigabatrin versus carbamazepine monotherapy for epilepsy.

Xiao Y, Gan L, Wang J, Luo M, Luo H.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008781. doi: 10.1002/14651858.CD008781.pub2. Review.

PMID:
22258989
18.

Vigabatrin therapy for refractory complex partial seizures: review of major European trials.

Ben-Menachem E, Sander JW.

Acta Neurol Scand Suppl. 2011;(192):16-28. doi: 10.1111/j.1600-0404.2011.01597.x. Review.

PMID:
22061177
19.

Epilepsy (partial).

Maguire M, Marson AG, Ramaratnam S.

BMJ Clin Evid. 2011 May 6;2011. pii: 1214.

20.

Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review.

Maguire MJ, Hemming K, Wild JM, Hutton JL, Marson AG.

Epilepsia. 2010 Dec;51(12):2423-31. doi: 10.1111/j.1528-1167.2010.02772.x. Epub 2010 Nov 10. Review.

PMID:
21070215
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk